utility: 
taiwan: Z01.252.474.872, Z01.639.850
multiple myeloma: C04.557.595.500, C14.907.454.460, C15.378.147.780.650, C15.378.463.515.460, C20.683.515.845, C20.683.780.650
epidemiologic studies: E05.318.760.500, N05.715.360.775.175, N06.850.520.450.500
color vision defects: C10.597.751.941.256, C11.966.256, C23.888.592.763.941.256
color: G01.590.540.199
steel: D01.490.800, D01.552.033.847, D25.058.807, J01.637.051.058.807
dermatitis, occupational: C17.800.174.255.700, C17.800.815.255.700, C24.270
upational: 
forced expiratory volume: E01.370.386.700.660.230, G09.772.650.430
vital capacity: E01.370.386.700.485.750.900, G09.772.850.970
isocyanate: 
suicide, attempted: F01.145.126.980.875.600, I01.880.735.856.600
rectal neoplasms: C04.588.274.476.411.307.790, C06.301.371.411.307.790, C06.405.249.411.307.790, C06.405.469.491.307.790, C06.405.469.860.180.500
perineum: A01.719
patients: M01.643
institute: 
registries: E05.318.308.970, L01.280.950, N04.452.859.819, N05.715.360.300.715.700, N06.850.520.308.970
residence characteristics: N01.224.791, N06.850.505.400.800
cause of death: E05.318.308.985.550.250, L01.280.975.550.250, N01.224.935.698.100, N06.850.505.400.975.550.250, N06.850.520.308.985.550.250
health surveys: E05.318.308.250, N05.715.360.300.375, N06.850.520.308.250
patient: 
age distribution: I01.240.050, N01.224.033, N06.850.505.400.050
dyspnea: C08.618.326, C23.888.852.371
median nerve: A08.800.800.720.050.500
sensation disorders: C10.597.751, C23.888.592.763
power plants: E07.305.437, J01.780
sex distribution: I01.240.800, N01.224.803, N06.850.505.400.850
educational status: N01.824.196
maternal age: G08.686.560, N05.715.350.075.550, N06.850.490.250.550
child behavior: F01.145.179
intelligence: F01.752.543
neurologic examination: E01.370.376.550, E01.370.600.550
sarcoidosis: C15.604.515.827
psychometrics: F04.711.780
prognosis: E01.789
dentists: M01.526.485.330, N02.360.330
ketoprofen: D02.241.223.701.480
tact: 
benzophenone: 
new zealand: Z01.639.760.747, Z01.678.100.747
zealand: 
antiprotozoal agents: D27.505.954.122.250.100
amyotrophic lateral sclerosis: C10.228.854.139, C10.574.562.250, C10.574.950.050, C10.668.467.250, C18.452.845.800.050
poisson distribution: E05.318.740.994.750, G17.820.750, N05.715.360.750.750.620, N06.850.520.830.994.750
population surveillance: E05.318.308.250.700, N05.715.360.300.375.625, N06.850.520.308.250.700, N06.850.780.675
urban health: N01.400.800
tality: 
diagnosis, differential: E01.171
facial dermatoses: C17.800.271
toallergic: 
suicide: F01.145.126.980.875, I01.880.735.856
ase: 
eruption: 
fatigue: C23.888.369
occupations: N01.824.547
hazardous waste: D20.944.380, D27.888.426.500, N06.850.460.710.380
school: 
sclerosis: C23.550.823
polyneuropathies: C10.668.829.800
railroads: J01.937.690
diagnosed: 
ethnic groups: M01.686.754, N01.224.317
attention deficit disorder with hyperactivity: F03.550.150.150
meningioma: C04.557.580.520, C04.557.645.520, C04.588.614.250.580.500, C10.551.240.500.500
neuroma, acoustic: C04.557.465.625.650.595.610, C04.557.580.600.610.595.610, C04.557.580.625.650.595.610, C04.588.614.596.240.015, C09.218.807.800.675, C09.647.675, C10.292.225.750, C10.292.910.600
telephone: L01.178.847.698
telephones: 
germany, west: Z01.542.315.440, Z01.586.315.440
infant, small for gestational age: M01.060.703.520.460.560
sampling studies: E05.318.760.875, N05.715.360.775.700, N06.850.520.450.875
infants: 
us: 
experience: 
pancreatic neoplasms: C04.588.274.761, C04.588.322.475, C06.301.761, C06.689.667, C19.344.421
cancers: 
psychological tests: F04.711
rural health: N01.400.650
children: 
survey: 
hodgkin disease: C04.557.386.355, C15.604.515.569.355, C20.683.515.761.355
lymphoma, non-hodgkin: C04.557.386.480, C15.604.515.569.480, C20.683.515.761.480
lip: A01.456.505.631.515, A14.549.336
cosmetic: 
chloralkali: 
update: 
noise, occupational: N06.230.400.500, N06.850.460.610.526
intelligence tests: F04.711.141.493
manufacturing: 
european continental ancestry group: M01.686.508.400
postmenopausal: 
utilization: 
thimerosal: D02.691.750.100.347.850
developmental disabilities: F03.550.362
reoperation: E04.690
vision disorders: C10.597.751.941, C11.966, C23.888.592.763.941
systematic: 
review: V02.600.500, V02.912
infant, low birth weight: M01.060.703.520.460
premature birth: C13.703.420.491.500
near: 
connecticut: Z01.107.567.875.550.200
polymorphism, single nucleotide: G05.365.795.598
prospective: 
factory: 
smelter: 
facility: 
subjects: 
mobile: 
stations: 
comorbidity: N05.715.350.225, N06.850.490.687
sweetened: 
sources: 
child development: F01.525.200, G07.700.320.374.750
fatal outcome: E05.318.308.985.550.325, L01.280.975.550.325, N01.224.935.698.201, N06.850.505.400.975.550.325, N06.850.520.308.985.550.325
renal dialysis: E02.870.300, E02.912.800
alveolitis, extrinsic allergic: C08.381.483.125, C08.674.055, C20.543.480.680.075
retrospective: 
family: F01.829.263, I01.880.225
powder: 
obstetric labor, premature: C13.703.420.491
carbon monoxide poisoning: C25.723.455.245
dizziness: C10.597.751.237, C23.888.592.763.237
breast neoplasms, male: C04.588.180.260, C17.800.090.500.260
causality: N05.715.350.200, N06.850.490.625
children's: 
interviews as topic: E05.318.308.420, L01.280.520, N05.715.360.300.400, N06.850.520.308.420
phones: 
cordless: 
coma: C10.597.606.358.800.200, C23.888.592.604.359.800.200
community: 
swedish: 
cleaning: 
child welfare: I01.880.787.293
vaccines: D20.215.894
sectional: 
transmission: 
dentistry: E06, H02.163
carbonated beverages: J02.200.300
pulmonary embolism: C08.381.746, C14.907.355.350.700
morbidity: E05.318.308.985.525, L01.280.975.525, N01.224.935.597, N06.850.505.400.975.525, N06.850.520.308.985.525
sensitized: 
legislation &amp; jurisprudence: 
color perception: F02.463.593.932.217
pneumonitis: 
employees: 
asthmatic: 
resin: 
dye: 
intraoperative complications: C23.550.505
diamond: D01.268.150.200
maldehyde: 
surveillance: 
umbilical cord: A16.378.693
contrast sensitivity: E01.370.380.850.950.500, F02.463.593.932.869.435.110, F02.463.593.932.901.500, G14.940.500
photocontact: 
physical examination: E01.370.600
cases]: 
rehabilitation: E02.831, H02.403.680.600, N02.421.784
dental restoration, permanent: E06.323.428, E06.780.345.737, E07.695.190.190
kidney calculi: C12.777.419.600.500, C12.777.967.249.500, C12.777.967.500.503, C13.351.968.419.600.500, C13.351.968.967.249.500, C13.351.968.967.500.503, C23.300.175.850.550
neuropsychological: 
social class: I01.880.552, I01.880.840.755, N01.824.782
acidosis: C18.452.076.176
resins, plant: D05.750.078.840, D20.215.721.500
mdi: 
clinical trials as topic: E05.318.760.535, E05.337.250, N05.715.360.775.235, N06.850.520.450.535
pharyngeal neoplasms: C04.588.443.665.710, C07.550.745, C09.647.710, C09.775.549
polymerization: G02.149.883
control: 
dermatitis, photoallergic: C17.800.174.255.100.600, C17.800.600.325, C17.800.815.255.100.600, C20.543.418.150.600
double-blind method: E05.318.780.300, E05.581.500.300, N05.715.360.780.320, N06.850.520.445.300
pneumoconiosis: C08.381.483.581, C08.381.520.702, C24.800
dermatitis: C17.800.174
follow: 
headache: C10.597.617.470, C23.888.592.612.441, C23.888.646.487
odds ratio: E05.318.740.600.600, G17.680.500, N05.715.360.750.625.590, N06.850.520.830.600.600
city: 
electric: 
birth: 
neuropsychological tests: F04.711.513
robehavioral: 
new york city: Z01.107.567.875.350.530.530, Z01.107.567.875.500.530.530, Z01.433.741
poland: Z01.542.248.679
prevalence: E05.318.308.985.525.750, L01.280.975.525.750, N01.224.935.597.750, N06.850.505.400.975.525.750, N06.850.520.308.985.525.750
retrospective studies: E05.318.760.500.500.500, E05.318.760.500.750.750, N05.715.360.775.175.200.710, N05.715.360.775.175.250.815, N06.850.520.450.500.500.500, N06.850.520.450.500.750.825
substance-related disorders: C25.775, F03.900
visual acuity: E01.370.380.850.950, F02.463.593.932.901, G14.940
years: 
allergy: 
updated: 
questionnaires: E05.318.308.750, L01.280.800, N05.715.360.300.695, N06.850.520.308.750
urban population: N01.600.900
parkinson disease, secondary: C10.228.140.079.862.800, C10.228.662.600.700
central nervous system neoplasms: C04.588.614.250, C10.551.240
case: 
confidence intervals: E05.318.740.275, N05.715.360.750.220, N06.850.520.830.275
indoor: 
cross-over studies: E05.318.780.150, N05.715.360.780.150, N06.850.520.445.150
ventilation: N06.230.150.520
symptoms: 
hematologic neoplasms: C04.588.448, C15.378.400
spirometry: E01.370.386.700.750
immunization: E02.095.465.425.400, E05.478.550, N02.421.726.758.310, N06.850.780.200.425, N06.850.780.680.310
paresthesia: C10.597.751.791.875, C23.888.592.763.770.875
rural population: N01.600.725
hard: 
precursor cell lymphoblastic leukemia-lymphoma: C04.557.337.428.600, C15.604.515.560.600, C20.683.515.528.600
england: Z01.542.363.300, Z01.639.280.300
gastrointestinal diseases: C06.405
fetal blood: A12.207.152.200, A15.145.300, A16.378.200
incidence: E05.318.308.985.525.375, L01.280.975.525.375, N01.224.935.597.500, N06.850.505.400.975.525.375, N06.850.520.308.985.525.375
health status: I01.240.425, N01.224.425, N06.850.505.400.425
new jersey: Z01.107.567.875.500.525
peak expiratory flow rate: E01.370.386.700.660.225.600, G09.772.650.300.790
findings: 
reactions: 
italy: Z01.542.489
occupational diseases: C24
attention: F02.830.104.214
dermatitis, allergic contact: C17.800.174.255.100, C17.800.815.255.100, C20.543.418.150
trichloroethanes: D02.455.526.439.927
milk, human: A12.200.467, J02.200.700.500, J02.500.350.525.500
prospective studies: E05.318.760.500.750.500.650, N05.715.360.775.175.250.630, N06.850.520.450.500.750.650
anti-inflammatory agents, non-steroidal: D27.505.696.663.850.014.040.500, D27.505.954.158.030, D27.505.954.329.030
cognitive: 
birth rate: E05.318.308.985.775.500, L01.280.975.775.500, N01.224.935.849.500, N06.850.505.400.975.775.500, N06.850.520.308.985.775.500
psychomotor disorders: C10.597.606.881, C23.888.592.604.882, F01.700.875
healthy: 
socioeconomic factors: I01.880.840, N01.824
cases: 
pregnancy outcome: E01.789.700, G08.686.785.760.769.530
men: M01.390
new: 
environment: G16.500.275, N06.230
hair: A17.360
cross reactions: G12.425.143.281
south africa: Z01.058.290.175.735
lung diseases, obstructive: C08.381.495
autopsy: E01.370.060, E05.070, I01.198.780.937.120
cross-sectional studies: E05.318.760.500.875, N05.715.360.775.175.275, N06.850.520.450.500.875
hip prosthesis: E07.695.400.400
meta: 
beta 2-microglobulin: D12.776.124.790.223.100, D12.776.377.715.182.100
longitudinal studies: E05.318.760.500.750.500, N05.715.360.775.175.250.450, N06.850.520.450.500.750.500
cord: 
respiratory function tests: E01.370.386.700
metallurgy: J01.576.370.400
cohort: 
abortion, spontaneous: C13.703.039
vision: 
neck: A01.598
silicosis: C08.381.483.581.760, C08.381.520.702.760, C24.800.834
sensory thresholds: F02.463.593.710
colostrum: A12.200.194
radiometry: E05.799
nutrition: 
functional laterality: F02.830.297.425, G11.561.225.425
sugar: 
respiration disorders: C08.618
cough: C08.618.248, C23.888.852.293
2000: 
pennsylvania: Z01.107.567.875.075.550, Z01.107.567.875.350.550, Z01.107.567.875.500.550
breast feeding: F01.145.407.199, G07.610.220.500.500, G07.610.593.185, G07.700.620.185
foam: 
vibration: G01.374.676.930, G01.595.540.930
erythema: C17.800.229
schistosomiasis: C03.335.865.859
finland: Z01.542.267
france: Z01.542.286
bronchial provocation tests: E01.370.386.700.125
therapy: 
epidemiologic methods: E05.318, N06.850.520
mandelic acids: D02.241.223.475, D02.241.511.536
outcomes: 
dermatitis, contact: C17.800.174.255, C17.800.815.255
aged, 80 and over: M01.060.116.100.080
motor skills: F02.808.260
epidemiology: H02.403.720.500
phone: 
dry: 
perception: F02.463.593
esophageal neoplasms: C04.588.274.476.205, C04.588.443.353, C06.301.371.205, C06.405.117.430, C06.405.249.205
tumours: 
congenital: 
breath tests: E01.370.100
follow-up studies: E05.318.760.500.750.500.350, N05.715.360.775.175.250.350, N06.850.520.450.500.750.350
young adult: M01.060.116.815
hip: A01.378.610.400
urticaria: C17.800.862.945, C20.543.480.904
treatment outcome: E01.789.800, N04.761.559.590.800, N05.715.360.575.575.800
proportional hazards models: E05.318.740.500.700, E05.318.740.600.700, E05.318.740.750.725, E05.318.740.998.825, E05.599.835.900, N05.715.360.750.530.650, N05.715.360.750.625.650, N05.715.360.750.695.650, N05.715.360.750.795.825, N06.850.520.830.500.700, N06.850.520.830.600.700, N06.850.520.830.750.725
national: 
man: 
infant, newborn: M01.060.703.520
carbon disulfide: D01.200.210, D01.875.350.850.074
danish: 
task performance and analysis: F02.784.412.846, F02.784.692.746, F02.808.600
mental disorders: F03
ethnology: I01.076.201.450.457
results: 
laundering: J01.576.549
pilot: 
cardiovascular diseases: C14
mortality: E05.318.308.985.550, L01.280.975.550, N01.224.935.698, N06.850.505.400.975.550, N06.850.520.308.985.550
radiography: E01.370.350.700
multivariate analysis: E05.318.740.150.500, N05.715.360.750.125.500, N06.850.520.830.150.500
massachusetts: Z01.107.567.875.550.510
smoking: F01.145.466.349.750, F01.145.928.500
examination: 
ships: J01.937.817
drug eruptions: C17.800.174.600, C20.543.206.380, C25.100.468.380
anatomy: H01.158.100
lung volume measurements: E01.370.386.700.485
drug hypersensitivity: C20.543.206, C25.100.468
psychomotor performance: F02.808, G11.427.700, G11.561.623
electric power supplies: E07.305.124
construction materials: J01.637.241
cosmetics: D27.720.269, J01.516.213
occupational: 
cognition: F02.463.188
chemical industry: J01.576.207
neurodegenerative diseases: C10.574
well: 
electromyography: E01.370.405.255, E01.370.530.255
elemental: 
australia: Z01.338, Z01.639.100, Z01.678.100.373
tary: 
parkinsonian disorders: C10.228.140.079.862, C10.228.662.600
disorders: 
mental recall: F02.463.425.540.641
vapour: 
methacholine compounds: D02.092.877.883.555, D02.675.276.534
ultrasonography: E01.370.350.850
alzheimer disease: C10.228.140.380.100, C10.574.945.249, F03.087.400.100
welders: 
agricultural workers' diseases: C24.080
mining: J01.576.370.500
netherlands: Z01.542.651
radionuclide imaging: E01.370.350.710, E01.370.384.730
adverse: 
exercise: G11.427.590.530.698.277, I03.350
industrial: 
california: Z01.107.567.875.580.200, Z01.107.567.875.760.200
new york: Z01.107.567.875.075.437, Z01.107.567.875.350.530, Z01.107.567.875.500.530
epidemiologic: 
tungsten: D01.268.556.887, D01.268.956.882, D01.552.544.887
body mass index: E01.370.600.115.100.125, E05.041.124.125, G07.100.100.125, N06.850.505.200.100.175
cyanates: D02.262
seafood: J02.500.600.875
overweight: C23.888.144.699, E01.370.600.115.100.160.120.699, G07.100.100.160.120.699
tobacco smoke pollution: D20.633.937.680, N06.850.460.100.555
ernal: 
north carolina: Z01.107.567.875.075.475, Z01.107.567.875.750.530
kidney failure, chronic: C12.777.419.780.750.500, C13.351.968.419.780.750.500
neonates: 
korean: 
cesarean section: E04.520.252.500
posture: G11.427.695
semen: A12.200.732
electricity: G01.358.500.249
among: 
report: 
beverages: J02.200
history: K01.400
life style: F01.829.458
logistic models: E05.318.740.500.525, E05.318.740.600.800.450, E05.318.740.750.450, E05.599.835.875, N05.715.360.750.530.480, N05.715.360.750.625.700.450, N05.715.360.750.695.470, N06.850.520.830.500.525, N06.850.520.830.600.800.450, N06.850.520.830.750.450
talc: D01.524.500.850, D01.578.725.500.800, D01.837.725.700.760.535.800
occupationally: 
women: M01.975
cardiovascular: 
fumigation: N06.850.780.200.300
styrenes: D02.455.426.559.389.150.750
dental amalgam: D25.339.208.291, J01.637.051.339.208.291
alcohol drinking: F01.145.317.269
food hypersensitivity: C20.543.480.370
pilot projects: E05.318.760.750, E05.337.737, N05.715.360.775.625, N06.850.520.450.720
memory disorders: C10.597.606.525, C23.888.592.604.529, F01.700.625
cellular phone: L01.178.847.698.300
poisoning]: 
denmark: Z01.542.808.224
aged: M01.060.116.100
magnetic resonance imaging: E01.370.350.500, E01.370.350.825.500
up: 
child: M01.060.406
urinary: 
peripheral nervous system diseases: C10.668.829
brain neoplasms: C04.588.614.250.195, C10.228.140.211, C10.551.240.250
trends: 
bone cements: D05.750.716.822.300, D25.720.716.822.300, D27.720.102.158, J01.637.051.720.716.822.300
confounding factors: 
aircraft: J01.937.285.100
base: 
african americans: M01.686.508.100.100, M01.686.754.100
asian continental ancestry group: M01.686.508.200
polyurethanes: D02.241.081.251.944.750, D05.750.716.650, D25.720.327.782, D25.720.716.650, J01.637.051.720.327.782, J01.637.051.720.716.650, J01.637.412.700
individuals: 
clinical: 
epidemiological monitoring: E05.318.375, N06.850.520.460
granuloma, foreign-body: C23.550.382.437, C26.392.560.325
neurobehavioral: 
echocardiography: E01.370.350.130.750, E01.370.350.850.220, E01.370.370.380.220
turkey: Z01.252.245.500.850, Z01.586.500.850
psychology: F04.096.628
population: N01.600
african continental ancestry group: M01.686.508.100
parity: G08.686.677, G08.686.785.760.769.472, N06.850.490.812.600
reaction time: F02.830.650, F04.669.817, G11.561.677
kidney function tests: E01.370.390.400
urinary bladder neoplasms: C04.588.945.947.960, C12.758.820.968, C12.777.829.813, C13.351.937.820.945, C13.351.968.829.707
trigeminal nerve: A08.800.800.120.760
contact: 
paint: J01.637.597
styrene: D02.455.426.559.389.150.750.800
tetrachloroethylene: D02.455.526.439.880
age: 
worker: 
data collection: E05.318.308, L01.280, N05.715.360.300, N06.850.520.308
rospective: 
french: 
switzerland: Z01.542.883
occupational health: N01.400.525
child, preschool: M01.060.406.448
childhood: 
mercury poisoning: C25.723.647
patch tests: E01.370.225.812.871.610, E05.200.812.871.610, E05.478.594.890.610
respiratory tract diseases: C08
absorptiometry, photon: E01.370.350.700.024, E05.196.712.224.187
movement disorders: C10.228.662
diabetes: 
air pollutants: D27.888.284.101
electrocardiography: E01.370.370.380.240, E01.370.405.240
methylmethacrylates: D02.241.081.069.800.550, D05.750.716.822.111.650.605, D25.720.716.822.111.650.605, J01.637.051.720.716.822.111.650.605
infant: M01.060.703
brain diseases: C10.228.140
bias: 
extended: 
colombia: Z01.107.757.284
hispanic americans: M01.686.754.441
postmenopause: G08.686.157.500.625, G08.686.785.880.249.500.625
health behavior: F01.145.488
chronic disease: C23.550.291.500
europe: Z01.542
ingestion: 
eye diseases: C11
toluene: D02.455.426.559.389.832
cognition disorders: F03.087.250
cer: 
chi-square distribution: E05.318.740.994.300, G17.820.300, N05.715.360.750.750.200, N06.850.520.830.994.300
methacholine chloride: D02.092.877.883.555.500, D02.675.276.534.500
autistic disorder: F03.550.325.125
food habits: F01.145.407.432, F01.145.466.349
neoplasms: C04
physical: 
emf: 
who: 
alloys: D01.552.033, D25.058, J01.637.051.058
vapors]: 
photosensitivity disorders: C17.800.600
neurodegenerative: 
sick building syndrome: C20.543.312.750, C21.223.750
epidemiological: 
essential: 
national institute for occupational safety and health: 
persons: M01
diet therapy: E02.642.249
air pollution, indoor: N06.850.460.100.080
cadmium poisoning: C25.723.165
research design: E05.581.500, H01.770.644.728
odors: G16.500.275.640, N06.230.480
substances: 
head: A01.456
2003: 
visual perception: F02.463.593.932
health: N01.400
nasopharyngeal neoplasms: C04.588.443.665.710.650, C07.550.350.650, C07.550.745.650, C09.647.710.650, C09.775.350.650, C09.775.549.650
arthroplasty, replacement, hip: E04.555.110.110.110, E04.650.110.110
bone density: G11.427.100
liver function tests: E01.370.372.460
granuloma: C15.604.515.292, C23.550.382
ohio: Z01.107.567.875.075.512, Z01.107.567.875.350.540, Z01.107.567.875.510.540
disease: C23.550.288
complications: 
isocyanates: D02.500
regression analysis: E05.318.740.750, N05.715.360.750.695, N06.850.520.830.750
disease progression: C23.550.291.656
mexico: Z01.107.567.589
pressure: G01.374.715
belgium: Z01.542.115
leukaemia: 
memory: F02.463.425.540
michigan: Z01.107.567.875.350.500, Z01.107.567.875.510.500
solvent: 
diet surveys: E05.318.308.250.600.350, E05.318.308.585.550.350, N05.715.360.300.375.560.300, N05.715.360.300.560.565.300, N06.850.520.308.250.600.350, N06.850.520.308.585.550.350
containing: 
areas: 
aldosterone: D04.808.745.745.654.062, D06.472.040.585.353.118
evoked potentials, somatosensory: G07.265.500.400, G11.561.270.400
liver diseases: C06.552
surgery: 
young: 
cohort studies: E05.318.760.500.750, N05.715.360.775.175.250, N06.850.520.450.500.750
tremor: C10.597.350.850, C23.888.592.350.850
intakes: 
bromide: 
risk factors: E05.318.740.600.800.725, N05.715.350.200.700, N05.715.360.750.625.700.700, N06.850.490.625.750, N06.850.520.830.600.800.725
food coloring agents: D27.720.233.674, D27.720.368.355
sweden: Z01.542.808.843
south: 
hearing: F02.830.816.263, G11.561.600.810.263
natriuresis: G08.852.796.241.557
hearing loss: C09.218.458.341, C10.597.751.418.341, C23.888.592.763.393.341
pulmonary edema: C08.381.742
multiple: 
audiometry: E01.370.382.375.060
risk: E05.318.740.600.800, G17.680.750, N05.715.360.750.625.700, N06.850.520.830.600.800
glioma: C04.557.465.625.600.380, C04.557.470.670.380, C04.557.580.625.600.380
toluene 2,4-diisocyanate: D02.455.426.559.389.832.500, D02.500.800
personal: 
spectrum analysis: E05.196.867
rubber: D25.720.099.750, D25.720.327.840, J01.637.051.720.099.750, J01.637.051.720.327.840, J01.637.412.767
great britain: Z01.542.363, Z01.639.280
quebec: Z01.107.567.176.791
diphenylmethane: 
wood: A18.700.888, J01.637.241.900
tomography, x-ray computed: E01.370.350.350.810, E01.370.350.600.350.700.810, E01.370.350.700.700.810, E01.370.350.700.810.810, E01.370.350.825.810.810
like: 
groups: 
oryza sativa: B01.650.940.800.575.100.822.616, J02.500.200.700
flavoring agents: D27.720.364, J02.500.512.400
risks: 
osteolysis: C05.116.264.579, G11.427.590.195.150.570
diabetes mellitus: C18.452.394.750, C19.246
idential: 
prosthesis design: E05.320.550, E07.695.680
potassium, dietary: D01.745.660
prostatic neoplasms: C04.588.945.440.770, C12.294.260.750, C12.294.565.625, C12.758.409.750
year: 
arsenic: D01.268.067, D01.268.513.249
residential: 
housing: N01.224.791.400, N06.230.150.360, N06.850.505.400.800.400
relation: 
aspirin: D02.455.426.559.389.657.410.595.176
sensitization: 
electric wiring: E07.305.245
occupational medicine: H02.403.720.750.510
radio waves: G01.358.500.505.810, G01.750.250.810, G01.750.770.721
asbestosis: C08.381.483.581.125, C08.381.520.702.125, C24.800.127
outcome: 
syndrome: C23.550.288.500
immunoglobulin e: D12.776.124.486.485.114.619.312, D12.776.124.790.651.114.619.312, D12.776.377.715.548.114.619.312
nervous system diseases: C10
nutrition surveys: E05.318.308.250.600, E05.318.308.585.550, N05.715.360.300.375.560, N05.715.360.300.560.565, N06.850.520.308.250.600, N06.850.520.308.585.550
urban: 
leukemia, myeloid, acute: C04.557.337.539.275
data: 
area: 
calcium, dietary: D01.146.315
leukemia, myeloid: C04.557.337.539
extremely: 
pleural neoplasms: C04.588.894.797.640, C08.528.694, C08.785.640
industry: J01.576
chlorine: D01.268.380.150, D01.362.225
allergic: 
biopsy: E01.370.225.500.384.100, E01.370.225.998.054, E01.370.388.100, E04.074, E05.200.500.384.100, E05.200.998.054, E05.242.384.100
asthma: C08.127.108, C08.381.495.108, C08.674.095, C20.543.480.680.095
metallic: 
welding: J01.576.370.400.900
oxybenzone: 
lead poisoning: C25.723.589
diisocyanate: 
middle aged: M01.060.116.630
sunscreening agents: D27.505.696.706.776.800, D27.505.954.444.695, D27.720.269.800, D27.720.799.763.764
infertility, male: C12.294.365.700
adults: 
benzophenones: D02.455.426.559.389.115.124, D02.522.223
air pollution: N06.850.460.100
allergens: D23.050.063
cause: 
reference standards: E05.978.808
poisoning: C25.723
carcinoma, renal cell: C04.557.470.200.025.390, C04.588.945.947.535.160, C12.758.820.750.160, C12.777.419.473.160, C13.351.937.820.535.160, C13.351.968.419.473.160
electroencephalography: E01.370.376.300, E01.370.405.245
electromagnetic: 
preliminary: 
dental: 
statistics &amp; numerical data: 
petroleum: D20.345.630, N06.230.132.258.630
workplace: N01.824.245.925, N04.452.677.975
quantitative: 
chromate: 
battery: 
radio: J01.897.280.500.739, L01.178.590.700, L01.178.820.090.739, L01.178.847.514
severity of illness index: E05.318.308.250.475.456.500, N05.715.360.300.375.375.364.500, N06.850.520.308.250.475.364.500
tartrazine: D02.172.950
prosthesis failure: C23.550.767.865, E05.325.771
visual: 
brazil: Z01.107.757.176
workers: 
living: 
group: 
plant: 
electromagnetic fields: G01.358.500.260, G01.358.750.500
plants: B01.650
glass: J01.637.241.400, J01.637.437
germany: Z01.542.315, Z01.586.315
diagnosis: E01
energy intake: G07.610.240.340
mothers: F01.829.263.500.320.200, I01.880.225.500.340.270, M01.620.630
electroplating: E05.301.250.348
hazards: 
plastics: D05.750.716, D25.720.716, J01.637.051.720.716
power: 
association: F02.463.425.069, F04.754.720.346
